NAME: ________________________

Combo with Antimycobacterials and 4 others Test

Question Types


Prompt With


Question Limit

of 122 available terms

5 Written Questions

5 Matching Questions

  1. sulfonamides
  2. sulfonamides MOA
  3. sulfonamides indications
  4. isoniazid, INH - MOR
  5. aminoglycosides MOR
  1. a broad spectrum; gram + and gram -
  2. b de novo synthesis of nucelotides need PABA; inhibit the actino of dihydropteroate synthase so block synthesis of dihydrofolate
  3. c adenylating, acetylation or phosphorylation of aminoglycosides
  4. d para-aminobenzoic acid (PABA)
  5. e mutated decrease in uptake of INH; **mutations of katG gene resulting in loss of catalase-peroxidase enzyme required for INH activation; b/c of resistance = can need tx for 2 yrs

5 Multiple Choice Questions

  1. PO; wide distribution* b/c TB can get into tissues even to caseous lesions; good distribution to CNS; metabolized by hepatic acetyltransferase - rapid/slow acetylators (30%=slow, can lead to toxicity of drug); most excreted as acetylated metabolite
  2. increased drug transport out of bacteria (efflux); mutations in the 50S that decrease binding of drug
  3. 4th generation; VERY broad; don't use; gram + coverage of 1st gen and gram - coverage of 3rd
  4. bacterial gain efflux pumps by conjugation
  5. 1st generation; effective against gram +!!; don't cross BBB

5 True/False Questions

  1. linezolid MOAbind to P site on 50S; for Gram +

          

  2. nafcillinantistaphyloccal; tx serious b-lactamase staph; for MSSA

          

  3. gram - cell wallouter membrane of lipopolysaccharide; harder to get into this cell

          

  4. quinolones and fluroquinolones MORmutate target, efflus or don't let it in

          

  5. M. tuberculosistuberculosis; 3% of the population infected; transmission = overcrowding, poor personal and public hygiene; * respiratory route; primary (caseous lesions) and secondary infection (reactivation)